These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 17086805)

  • 1. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
    Cyriac S; Rajendranath R; Sridevi V; Sagar TG
    J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
    Cagayan MS; Lu-Lasala LR
    J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
    Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Wan XR; Sun ZJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of high-risk gestational trophoblastic disease.
    Lurain JR
    J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm].
    Feng FZ; Xiang Y; Cao Y; Li L; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):728-31. PubMed ID: 19087536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
    Kohorn EI
    Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.